Latest news
MID PENN BANCORP INC Q2 2026: Revenue $65.3M, EPS $0.85— 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:35:07 GMTCumberland Pharmaceuticals Q2 Earnings Call Highlights - TradingViewTradingView · Tue, 04 Aug 2026 23:04:01 GMTCumberland Pharmaceuticals Q2 loss widens after Apotex transaction - TradingViewTradingView · Tue, 04 Aug 2026 22:33:50 GMTCumberland reports Q2 2026: $4.1M quarterly net loss, $1.50 special dividend after $100M strategic deal - TradingViewTradingView · Tue, 04 Aug 2026 21:23:01 GMTCPIX: Closed $100M asset sale, paid special dividend, and advanced late-stage clinical pipeline - TradingViewTradingView · Tue, 04 Aug 2026 21:20:12 GMT